Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 鈥� Conference Call to Follow
Ekso Bionics (NASDAQ:EKSO), a leader in medical and industrial exoskeleton technology, has scheduled its Q2 2025 financial results release for July 28, 2025 after market close. The company will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss financial performance and recent business developments.
Investors can join via phone by dialing 877-407-6184 (domestic) or 201-389-0877 (international). The presentation will also be available through a live webcast and archived on the company's investor relations website.
Ekso Bionics (NASDAQ:EKSO), leader nella tecnologia di esoscheletri medici e industriali, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 28 luglio 2025 dopo la chiusura del mercato. La societ脿 terr脿 una conference call alle 13:30 PT / 16:30 ET per discutere delle performance finanziarie e degli ultimi sviluppi aziendali.
Gli investitori potranno partecipare telefonicamente chiamando il 877-407-6184 (nazionale) o il 201-389-0877 (internazionale). La presentazione sar脿 inoltre disponibile tramite webcast in diretta e archiviata sul sito web delle relazioni con gli investitori della societ脿.
Ekso Bionics (NASDAQ:EKSO), l铆der en tecnolog铆a de exoesqueletos m茅dicos e industriales, ha programado la publicaci贸n de sus resultados financieros del segundo trimestre de 2025 para el 28 de julio de 2025 despu茅s del cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia a las 1:30 PM PT / 4:30 PM ET para discutir el desempe帽o financiero y los desarrollos recientes del negocio.
Los inversionistas pueden unirse por tel茅fono marcando 877-407-6184 (nacional) o 201-389-0877 (internacional). La presentaci贸n tambi茅n estar谩 disponible mediante una transmisi贸n en vivo y archivada en el sitio web de relaciones con inversionistas de la compa帽铆a.
Ekso Bionics (NASDAQ:EKSO)電� 鞚橂 氚� 靷办梾鞖� 鞕戈敞瓴� 旮办垹 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 2025雲� 2攵勱赴 鞛鞁れ爜鞚� 2025雲� 7鞗� 28鞚� 鞛� 毵堦皭 頉� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 鞛 靹标臣 氚� 斓滉芳 靷梾 霃欗枼鞐� 雽�頃� 雲检潣頃橁赴 鞙勴暣 鞓ろ泟 1:30 PT / 鞓ろ泟 4:30 ET鞐� 旎嵓霟办姢 旖滌潉 臧滌禍頃╇媹雼�.
韴瀽鞛愲摛鞚� 甑偞 鞝勴檾 877-407-6184 霕愲姅 甑牅 鞝勴檾 201-389-0877搿� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 氚滍憸電� 霛检澊敫� 鞗轨簮鞀ろ姼搿滊弰 鞝滉车霅橂┌ 須岇偓 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐� 鞎勳勾鞚措笇霅╇媹雼�.
Ekso Bionics (NASDAQ:EKSO), leader dans la technologie des exosquelettes m茅dicaux et industriels, a pr茅vu la publication de ses r茅sultats financiers du deuxi猫me trimestre 2025 pour le 28 juillet 2025 apr猫s la cl么ture du march茅. La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 13h30 PT / 16h30 ET pour discuter des performances financi猫res et des d茅veloppements r茅cents de l'entreprise.
Les investisseurs peuvent participer par t茅l茅phone en composant le 877-407-6184 (national) ou le 201-389-0877 (international). La pr茅sentation sera 茅galement disponible via un webinaire en direct et archiv茅e sur le site des relations investisseurs de la soci茅t茅.
Ekso Bionics (NASDAQ:EKSO), ein f眉hrendes Unternehmen im Bereich medizinischer und industrieller Exoskelett-Technologie, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 28. Juli 2025 nach B枚rsenschluss geplant. Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz abhalten, um die finanzielle Leistung und aktuelle Gesch盲ftsentwicklungen zu besprechen.
Investoren k枚nnen telefonisch unter 877-407-6184 (national) oder 201-389-0877 (international) teilnehmen. Die Pr盲sentation wird auch per Live-Webcast verf眉gbar sein und auf der Investor-Relations-Website des Unternehmens archiviert.
- None.
- None.
SAN RAFAEL, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the 鈥淐ompany鈥�), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter of 2025 after the close of trading on Monday, July 28, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments.
To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company鈥檚 website at under 鈥淧resentations & Events鈥� in the Investors section.
About Ekso Bionics庐
Ekso Bionics庐 is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Based upon its industry-leading expertise, the Company focuses on improving health and quality of life with advanced robotics designed to enhance, amplify, and restore聽human function. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol 鈥淓KSO.鈥� For more information, visit: .
Contact:
Stephen Kilmer
Investor Relations
Direct: (646) 274-3580
Email:
FAQ
When will Ekso Bionics (EKSO) release Q2 2025 earnings?
What time is the Ekso Bionics Q2 2025 earnings call?
How can I listen to Ekso Bionics (EKSO) Q2 2025 earnings call?
Where can I find the replay of Ekso Bionics Q2 2025 earnings call?
